Doxorubicin is a widely used chemotherapy medication in the treatment of breast cancer, lymphomas, leukemias, and sarcomas. It is often included in standard treatment protocols due to its broad activity against different types of cancer.

It belongs to a class of drugs known as anthracyclines, which are known for their ability to interact directly with DNA.

Doxorubicin works by inserting itself between DNA base pairs, a process known as intercalation. It also inhibits enzymes such as topoisomerase II, which are necessary for DNA replication and repair. These combined effects may disrupt cancer cell division and lead to cell death.

In addition, doxorubicin may generate free radicals, which can further damage cellular components. However, because it can also affect normal cells, particularly those in the heart and bone marrow, careful monitoring is often required during treatment.